Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Sep 21, 2023

BUY
$0.3 - $2.74 $6,420 - $58,636
21,400 Added 71.33%
51,400 $24,000
Q2 2022

Aug 15, 2022

BUY
$0.3 - $2.74 $6,420 - $58,636
21,400 Added 71.33%
51,400 $24,000
Q1 2022

Sep 21, 2023

BUY
$2.13 - $3.85 $11,715 - $21,175
5,500 Added 22.45%
30,000 $69,000
Q1 2022

May 16, 2022

BUY
$2.13 - $3.85 $11,715 - $21,175
5,500 Added 22.45%
30,000 $69,000
Q4 2021

Sep 21, 2023

SELL
$3.39 - $6.76 $26,103 - $52,052
-7,700 Reduced 23.91%
24,500 $92,000
Q4 2021

Feb 14, 2022

BUY
$3.39 - $6.76 $83,055 - $165,620
24,500 New
24,500 $92,000
Q3 2021

Nov 15, 2021

SELL
$2.1 - $5.19 $67,620 - $167,118
-32,200 Closed
0 $0
Q2 2021

Sep 21, 2023

SELL
$4.68 - $7.39 $613,080 - $968,090
-131,000 Reduced 80.27%
32,200 $150,000
Q2 2021

Aug 20, 2021

SELL
$4.68 - $7.39 $14.9 Million - $23.6 Million
-3,187,800 Reduced 99.0%
32,200 $151,000
Q2 2021

Aug 16, 2021

BUY
$4.68 - $7.39 $15.1 Million - $23.8 Million
3,220,000 New
3,220,000 $151,000
Q1 2021

May 14, 2021

SELL
$6.81 - $10.55 $1.11 Million - $1.72 Million
-163,200 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$3.33 - $7.18 $543,456 - $1.17 Million
163,200 New
163,200 $1.17 Million
Q2 2020

Aug 14, 2020

SELL
$3.07 - $4.68 $327,876 - $499,823
-106,800 Reduced 39.56%
163,200 $560,000
Q1 2020

May 15, 2020

SELL
$2.28 - $6.6 $592,800 - $1.72 Million
-260,000 Reduced 49.06%
270,000 $999,000
Q4 2019

Feb 13, 2020

BUY
$3.34 - $5.51 $334,000 - $551,000
100,000 Added 23.26%
530,000 $2.49 Million
Q3 2019

Nov 13, 2019

SELL
$2.23 - $4.61 $1.32 Million - $2.74 Million
-594,100 Reduced 58.01%
430,000 $1.38 Million
Q4 2018

Feb 14, 2019

BUY
$7.3 - $18.3 $3.03 Million - $7.6 Million
415,100 Added 68.16%
1,024,100 $7.48 Million
Q3 2018

Nov 14, 2018

BUY
$9.77 - $17.15 $5.18 Million - $9.09 Million
530,200 Added 672.84%
609,000 $10.2 Million
Q2 2018

Aug 14, 2018

BUY
$5.43 - $9.83 $427,884 - $774,604
78,800 New
78,800 $743,000

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.